Wesper
Wesper Inc.
Experience PSG-level sleep testing—without wires, belts, or labs. Wesper is FDA-cleared, 95% correlated to in-lab studies, and delivers results in under 20 minutes. Trusted by 200+ providers.
wesper.co · New York, NY
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$8.3M of $8.3M
Filed2026-07-14
Days since filing82
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2024-03-05
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- AMIR REUVENYExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged100% sold30.9 months since first sale
Prior raiseNot flagged$9.6M prior raiseprior filing 2026-07-14
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.